-+ 0.00%
-+ 0.00%
-+ 0.00%

Curasight Nets DKK16 Million From Share Issue, Enters DKK40 Million Loan Agreement

MT Newswires·12/14/2025 06:32:55
Listen to the news
06:32 AM EST, 12/14/2025 (MT Newswires) -- Curasight (CURAS.CO) raised 16.4 million Danish kroner from a directed issue of 2,055,330 shares and secured a loan facility worth 40 million kroner. The Danish biotechnology company's shares were sold at 7.98 kroner apiece through an accelerated bookbuilding procedure, according to a Dec. 12 release. Meanwhile, Fenja Capital II agreed to provide the loan in two tranches of 25 million kroner and 15 million kroner, respectively, with the first tranche structured as a convertible loan. The total financing will support the clinical development of uTRACE and uTREAT and boost Curasight's financial position.